Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Worldwide Offices
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Visiongain Report Claims there is Huge Potential Within the $28bn Stem Cell Technologies and Applications Market

      - Global Stem Cell Technologies and Applications Market 2019-2029

      - Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications

      This image opens in the lightbox

      News provided by

      Visiongain

      30 Sep, 2019, 09:00 GMT

      Share this article

      Share this article


      LONDON, Sept. 30, 2019 /PRNewswire/ -- The global stem cell technologies and applications market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 12.3% in the first half of the forecast period.

      How this report will benefit you
      Read on to discover how you can exploit the future business opportunities emerging in this sector.

      In this brand new 292-page report you will receive 110 charts– all unavailable elsewhere.

      The 292-page Visiongain report provides clear detailed insight into the global stem cell technologies and applications market. Discover the key drivers and challenges affecting the market.

      By ordering and reading our brand-new report today you stay better informed and ready to act.

      To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-stem-cell-technologies-and-applications-market-2019-2029/#download_sampe_div

      Report Scope

      • Global Stem Cell Technologies and Applications Market forecasts from 2019-2029

      • Global Stem Cell Technologies and Applications submarket forecasts from 2019-2029:
      • Cancer treatment
      • Cardiovascular therapy
      • CNS
      • Other therapies
      • Non-therapeutic applications

      • Individual revenue forecast to 2029 for selected top products:
      • MSC-100-IV (Mesoblast)
      • Hearticellgram-AMI (Pharmicell)
      • CardioRel (Reliance Life Sciences)
      • Osteocel Plus (NuVasive)
      • Trinity Evolution and Elite (Orthofix)
      • CARTISTEM (MEDIPOST)

      • Analysis of the most promising pipeline therapies in each therapeutic segment

      • Discussion on regulatory environments and developments in the US, Japan, Europe and other leading countries

      • Analysis of what drives and restrains the market

      • This study also discusses other influences on that field, including these:
      • Haematopoietic stem cell transplantation (HSCT)
      • Embryonic stem cells (ESCs), induced pluripotent adult (IPSCs) and parthenogenetic cells
      • Uses for umbilical cord blood and related technologies, including cellular and blood banking
      • Agents for osteogenesis and treating autoimmune conditions
      • Applications in cell-based assays, diagnostics and drug development.

      • Key questions answered by this report:
      • What is the size of the total stem cells market, and how will the market evolve between 2019 and 2029
      • How will the main segments within the overall stem cells market develop between 2019-2029
      • What are the main drivers and restraints that will shape the overall stem cells market, and its individual segments over the next ten years?
      • What is the state of stem cell research in the different therapeutic segments?
      • What are some of the most prominent companies within this space, and what are their latest developments?
      • What are the most promising pipeline therapies in each therapeutic segment?
      • What are the revenue prospects for some of the stem cell therapies which have already been approved?
      • What are the main strengths, weaknesses, opportunities and threats for the stem cell market?
      • What are the main social, technological, economic and political factors that influence this market?

      To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-stem-cell-technologies-and-applications-market-2019-2029/

      Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

      Companies covered in the report include:

      Aastrom Biosciences
      Advanced Cell Technology
      Alder Biopharmaceuticals
      Alkem
      AllCells
      Allergan
      AlloSource
      Americord
      Americord
      Amgen
      Amgen
      Angiocrine Bioscience
      Angiocrine Bioscience
      Anterogen
      Anterogen
      Apceth
      Arteriocyte
      Arteriocyte
      Associated Press
      Astellas Pharma
      Asterias Biotherapeutics
      Asterias Biotherapeutics
      Athersys
      Athersys
      Auriga Ventures
      Axiogenesis
      Axiogenesis
      Bank a Tooth
      Baxter
      Baxter Healthcare
      BaYi Brain Hospital
      BioCardia
      BioCardia
      BioE
      BioE
      BioEden
      BioEden
      Biogenea-Cellgenea
      Bioheart, Inc.
      Biologic Therapies
      BioMet Orthopedics
      Biosciences
      BioTechnology
      BioTime
      BioTime Asia
      Blackstone
      Blackstone Medical
      Bloodworks
      Bluebird Bio
      Brain Somatic Mosaicism
      BrainStorm Cell Therapeutics
      Caladrius Biosciences
      California Institute for Regenerative Medicine (CIRM)
      Calimmune
      Capricor
      Cardio3
      Caribou
      Carolinas Cord Blood Bank (CCBB)
      Casey Eye Institute
      Cedars-Sinai Heart Institute
      Celgene
      Cell Cure Neurosciences
      Cell Research Groups
      Cell Therapy Catapult
      Cellartis
      CellCentric
      Cellectis
      Cellerant Therapeutics
      Cellerix
      CELLTREE
      Cellular Biomedicine Group (CBMG)
      Cellular Dynamics International
      Center for International Blood and Marrow Transplant Research (CIBMTR)
      Centers for Medicare & Medicaid Services
      Cephalon
      Cesca Therapeutics
      Ceylad
      China Cord Blood Corporation
      China Cord Blood Corporation
      China Regenerative Medicine International Limited (CRMI)
      Chugai Pharmaceutical Co. Ltd.
      CJ CheilJedang
      Clal Biotechnologies Industries
      Cleveland Biolabs
      Cleveland Cord Blood Center
      ClinImmune Labs
      Cochrane
      Cognate BioServices
      Cook General BioTechnology
      Cord Blood America
      Cordlife Group
      CordVida
      CRISPR Therapeutics
      Cryo-Cell International
      CryoCord
      CryoHaldco
      Cryonix CJSC
      Cryo-Save
      CryoViva
      CXR Biosciences
      Cytori Therapeutics
      Denali Ventures
      Dendreon
      Dong-A Pharmaceuticals Co.
      Dynamics
      Elbit Imaging
      Elbit Medical Technologies
      Eli Lilly
      EpiStem
      ESI BIO
      EuroStemCell
      Fate Therapeutics
      FDS Pharma
      Fondazione Centro San Raffaele
      Fondazione Telethon
      Forbion Capital Partners
      Forticell Bioscience
      Future Health Biobank
      Gamida Cell
      Gemabank
      Gene Cell International
      Genetico
      Genetrix Group
      Geron Corporation
      Gilead
      GlobalStem
      Globocan
      GSK
      Howard Hughes Medical Institute
      Human Stem Cells Institute
      ImmunoCellular Therapeutics
      Immunovative Therapies
      Indian Department of Biotechnology
      Insception Biosciences
      Intellia Therapeutics
      IntelliCell Biosciences
      IPS Academia Japan
      Isar Medical Centre
      Israel Healthcare Venture
      Japan Institute of Biomedical Research.
      JCR Pharmaceuticals
      JingYuan Bio.
      Johnson & Johnson
      Kirby Institute
      Lifebank Cryogenics
      LifebankUSA
      LifeCord
      LifeMap Sciences
      LifeMap Solutions
      LifeSouth Community Blood Centers Inc
      Lonza
      Maxcyte
      Mayo Clinic
      MedCell Bioscience
      MEDIPOST
      Medistem Panama
      Medistem Panama Inc.
      Medtronic
      Mesoblast
      Miltenyi Biotec
      National Dental Pulp laboratory
      NeoStem
      Neuralstem
      New England Cord Blood Bank
      New York Blood Center
      Novartis
      NovoCell
      NurOwn
      Nuvasive
      Ocata Therapeutics
      OncoCyte
      Opexa Therapeutics
      OrLife Bio
      Orthofix
      Osiris Therapeutics
      Pahrump Valley Times
      Pfizer
      Pharmicell
      Pharmsynthez
      Plasticell
      Pluristem Therapeutics
      Polyphor
      Precious Cell Group
      Prix Galien
      PsychENCODE
      Pulp Laboratory
      Q Therapeutics
      Quest Biomedical
      ReCyte Therapeutics
      Ree Labs
      Regenerative Sciences
      Regenerex
      Regeneron
      Regeneus
      Reliance Group
      Reliance Life Sciences
      ReNeuron
      RepliCel Life Sciences
      Reprobank
      ReproCELL
      RIKEN Center for Developmental Biology
      Roche
      Roslin Cellab
      RTI Biologics
      RTI Surgical
      RUSNANO Corporation
      RVC OJSC
      SanBio
      Sangamo BioSciences
      Sanofi
      S-Evans Biosciences
      Spinesmith Partners
      SSM Cardinal Glennon
      SSM Cardinal Glennon Children's Medical Center
      Stem Cell Bank
      Stemade
      Stemcell Technologies
      StemCore
      StemCyte
      Stemedica Cell Technologies
      StemGen
      StemImmune Inc
      Stemina Biomarker Discovery
      StemSave
      Store-a-tooth
      SynBio
      Systems
      Takara Bio
      Takeda
      TAP Biosystems
      Teva
      The Zon Laboratory
      TiGenix
      Tong Yuan Stem Cell
      Tooth Bank
      TrakCel
      Transcell Biologics Pvt Ltd.
      Translational Biosciences
      U.S. Stem Cell, Inc
      UCL Business PLC
      UCL Institute of Ophthalmology
      UCLA
      uniQure
      US Stem Cell, Inc.
      Valeant
      VAULT Sc Inc.
      Vericel Corporation
      Vericel Corporation
      Vesta Therapeutics
      ViaCord
      ViaCyte
      ViroMed
      Vita34
      Vitro Biopharma
      WA Optimum Health Care
      WHO

      List of Organisations Mentioned in the Report
      American Academy of Neurology
      American Academy of Pediatrics (AAP)
      American Neurological Associates Annual Meeting
      American Society of Blood and Marrow Transplantation.
      Americas Committee for Treatment and Research in Multiple Sclerosis
      Boston Children's Hospital
      Cha General Hospital
      China Food and Drug Administration (CFDA)
      Chinese Academy of Sciences
      Chinese Ministry of Health
      Chinese Ministry of Science and Technology
      Committee for Medicinal Products for Human Use (CHMP)
      Consortium of Multiple Sclerosis Centers
      Cord Blood Registry
      Duke University School of Medicine
      EMA
      European Court of Human Rights
      European Court of Justice
      European Group for Blood and Marrow Transplantation (EBMT)
      European Haematology Association
      Federal D.C. Court of Appeals
      Harvard Business School
      Harvard Stem Cell Institute
      Harvard University
      Human Fertilisation and Embryology Authority (HFEA)
      Human Tissue Authority
      International Society for Stem Cell Research (ISSCR)
      International Stem Cell Corporation (ISCO)
      International Stemcell Services
      Israel Stem Cell Society
      Japan's Ministry of Economy, Trade and Industry (METI)
      Japanese Health Ministry
      Japanese Ministry of Labour and Welfare (MHLW)
      Japanese Pharmaceuticals and Medical Devices Agency
      Karolinska Institute
      Korean Food and Drug Administration
      Korean MFDS (Ministry of Food and Drug Safety)
      Massachusetts General Hospital
      McMaster University
      Musculoskeletal Transplant Foundation (MTF)
      New York Heart Association
      NHS Blood and Transplant Authority
      Northwestern University
      Novartis Research Foundation
      Oregon Health and Science University
      Psychiatric Gene Networks
      Queen Mary University of London
      Tel Aviv University
      The European Commission
      The Marcus Foundation
      UK Care Quality Commission
      UK Department of Health
      UK Department of Health and the Medical Research Council
      UK Home Office
      UK Medicines and Healthcare Products Regulatory Agency (MHRA)
      UK National Institute for Health Research
      UK Regenerative Medicine Platform
      United Nation's Department of Economic and Social Affairs
      University of California
      University of Colorado Anschutz Medical Campus (AMC)
      University of Colorado Cord Blood Bank
      University of Kyoto
      University of Massachusetts
      University of Washington
      University of Western Ontario
      University of Wisconsin Alumni Research Foundation
      US Congress
      US District Court for the District of Columbia
      US FDA
      US National Cord Blood Program
      US National Institute of Allergy and Infectious Diseases (NIAID)
      US National Institute of Health (NIH)
      US Patent and Trademark Office
      US Supreme Court
      Yale University

      To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

      Related reports:

      Global Precision Medicine Market Forecast 2019-2029

      Checkpoint Inhibitors for Anti-Cancer Treatment Market 2019-2029

      Biobanking Market Forecasts 2019-2029

      Global Graft versus Host Disease (GVHD) Market 2019-2029

      Top 25 Translational Regenerative Medicine Manufacturers 2019 

      Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.